ABBV lowers adjusted earnings guidance for 2024 from $10.71-$10.91 per share to $10.67-$10.87 to account for acquisition costs.

American pharmaceutical giant AbbVie ($ABBV) abruptly lowered its Q3 and full year Fiscal 2024 earnings expectations owing to ...

While it isn’t clear what triggered the $82 million payment, the announcement comes a week after AbbVie said that its ...

Your browser does not support the video tag. Bitcoin.com’s V-Card enables you to spend cryptocurrency anywhere Mastercard® is accepted. You can top up the card ...